Windtree Therapeutics Inc At KOL Webinar on Istaroxime For The Treatment Of Acute Heart Failure And The Upcoming Data In Early Cardiogenic Shock Call Transcript
Good morning, and welcome to the Windtree Pharmaceutical's KOL webinar on istaroxime for the treatment of acute heart failure and the upcoming data in early cardiogenic shock. (Operator Instructions) As a reminder, this call is being recorded, and a replay will be made available on the Windtree website following the conclusion of the event.
I'd now like to turn the call over to Craig Fraser, President and Chief Executive Officer of Windtree. Please go ahead, Craig.
Thanks, Tara. Good morning, everybody. I was looking forward to joining you all this morning. Thanks for logging in. We have a number of topics to talk to you about this morning, and Windtree has a good bit of activity with some near-term milestones. So this is very timely for us to be connecting with you.
Next slide, please. This morning, I'm going to be making some forward-looking comments. So if you could please refer to our public filings, you can find those on our web address at
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
